Literature DB >> 23990053

Crimean-Congo hemorrhagic fever virus nucleoprotein suppresses IFN-beta-promoter-mediated gene expression.

Luka Fajs1, Katarina Resman, Tatjana Avšič-Županc.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is a member of the family Bunyaviridae and is a causative agent of severe hemorrhagic disease. Knowledge regarding the pathogenesis of CCHFV is limited due to the requirement for high-containment laboratories and the lack of an immunocompetent animal host. Previous studies have shown that CCHFV delays the activation of the human innate immune response, specifically, the type I interferon response. Our study results show that antagonism of the interferon-beta promoter is mediated by the nucleoprotein of CCHFV strain Hoti, while strains IbAr10200 and AP92 do not suppress the activity of the IFN-beta promoter. Our results also suggest that several viral factors may provide antagonistic action against the type I interferon response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990053     DOI: 10.1007/s00705-013-1816-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

Review 1.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

2.  Genomic Characterization of the Genus Nairovirus (Family Bunyaviridae).

Authors:  Jens H Kuhn; Michael R Wiley; Sergio E Rodriguez; Yīmíng Bào; Karla Prieto; Amelia P A Travassos da Rosa; Hilda Guzman; Nazir Savji; Jason T Ladner; Robert B Tesh; Jiro Wada; Peter B Jahrling; Dennis A Bente; Gustavo Palacios
Journal:  Viruses       Date:  2016-06-10       Impact factor: 5.048

3.  Characterization of Biomarker Levels in Crimean-Congo Hemorrhagic Fever and Hantavirus Fever with Renal Syndrome.

Authors:  Miša Korva; Katarina Resman Rus; Miša Pavletič; Ana Saksida; Nataša Knap; Mateja Jelovšek; Katja Strašek Smrdel; Xhevat Jakupi; Isme Humolli; Jusuf Dedushaj; Miroslav Petrovec; Tatjana Avšič-Županc
Journal:  Viruses       Date:  2019-07-26       Impact factor: 5.048

4.  Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).

Authors:  Elif Karaaslan; Nesibe Selma Çetin; Merve Kalkan-Yazıcı; Sevde Hasanoğlu; Faruk Karakeçili; Aykut Özdarendeli; Ahmet Kalkan; Ali Osman Kılıç; Mehmet Ziya Doymaz
Journal:  PLoS Negl Trop Dis       Date:  2021-12-01

5.  HMGB1 Is a Potential Biomarker for Severe Viral Hemorrhagic Fevers.

Authors:  Katarina Resman Rus; Luka Fajs; Miša Korva; Tatjana Avšič-Županc
Journal:  PLoS Negl Trop Dis       Date:  2016-06-27

Review 6.  Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development.

Authors:  Thomas Tipih; Felicity Jane Burt
Journal:  Biores Open Access       Date:  2020-05-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.